Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Molecular Characterization of SOCS1-Mediated Regulation of the GM-CSF Receptor

EF 2012-13

Résumé
Juvenile myelomonocytic leukemia (JMML) is a highly aggressive cancer that affects young children. There is no cure or effective treatment for JMML, which has an average survival rate of less than 20% past three years of diagnosis. A hallmark feature that defines and underlies JMML is the inordinately increased ability of leukemic cells to grow in the presence of granulocyte macrophage-colony stimulating factor (GM-CSF), a substance produced by cells to promote cell proliferation, via an unknown mechanism. This proposal aims to provide insightful mechanistic understanding of how GM-CSF causes this increased growth potential of leukemic cells that is responsible for the pathogenesis of JMML. Ultimately, I hope that the findings in this research endeavor will contribute towards the development of better cancer therapeutics for the management of children with JMML.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
279448
Name
Kommaraju Kamya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Molecular Characterization of SOCS1-Mediated Regulation of the GM-CSF Receptor
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Gm-Csf; Jak2; Juvenile Myelomonocytic Leukemia; Socs1; Ubiquitin
Abstract
Juvenile myelomonocytic leukemia (JMML) is a highly aggressive cancer that affects young children. There is no cure or effective treatment for JMML, which has an average survival rate of less than 20% past three years of diagnosis. A hallmark feature that defines and underlies JMML is the inordinately increased ability of leukemic cells to grow in the presence of granulocyte macrophage-colony stimulating factor (GM-CSF), a substance produced by cells to promote cell proliferation, via an unknown mechanism. This proposal aims to provide insightful mechanistic understanding of how GM-CSF causes this increased growth potential of leukemic cells that is responsible for the pathogenesis of JMML. Ultimately, I hope that the findings in this research endeavor will contribute towards the development of better cancer therapeutics for the management of children with JMML.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kommaraju, Kamya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~